Scholars Central

Review articlePublished 2016

Epigenetics and Immunotherapy: New Perspective for Breaking Chronic Viral Infection

Authors: Jiabin Yan

Immunotherapy: Open Access

Volume 2 · Issue 1 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Chronic or persistent viral infections, like HBV, HCV and HIV, are still a challenge for human health. More importantly, most human chronic viral infection will result in cancer, the top leading cause of death. So far antiviral drugs and immunotherapy have limited therapeutic effects on patients. New potential mechanisms of chronic viral infections are needed to explore before new effective therapeutic strategies can be put into use. Epigenetic alterations are an important hallmark of cancer. Recent studies indicate that chronic viral infections also induce epigenetic changes in the host. This review will try to summarize some of the most recent studies in these fields and explore a new strategy to break chronic viral infection by combining epigenetic therapy and immunotherapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Immunotherapy: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalImmunotherapy: Open Access
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Jiabin Yan”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels